Manufacturing partner will provide all that is needed and plenty more. Current shareholders are sitting on the ultimate goldmine. I'll concur, the current trial is taking way too long. But, I do agree that by the time it became evident, the only logical choice was to ride it out in Australia. Yet, one has to ask themselves, given the decision to extend the trial to look for more data as it pertains to possible anomalous results, what might management know about the future of the balance sheet?
Manufacturing partner will provide all that is needed and plenty...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
